**Meet the editor**

Ibeh Bartholomew, PhD, is currently the acting director/ head of Medical Biotechnology Department, National Biotechnology Development Agency, Abuja, Nigeria. He holds a doctoral degree in Medical Biochemistry/ Immunochemistry. He has obtained several grants and awards. Dr. Ibeh has served as an external examiner and supervised over 30 university students on various

HIV research topics. Though his work on HIV serodiscordant infection in blacks is widely acknowledged, his current research interest is on development of efficient immunodeficient mouse models using CRISPR/Cas9-mediated genome engineering technique. He is a member of the International Union of Biochemistry and Molecular Biology and the Nigerian Society of Biochemistry and Molecular Biology.
